|
 Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), today announced that it has received new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new dermatology indications for Microcyn® Skin and Wound HydroGel.
|
|
 Is there a partner out there for picoplatin? This is obviously the most significant question for the company right now, in addition to what the FDA will say about the SCLC data
|
 Shares of BioElectronics enjoyed a nice jump in price this week based on the release of an interview with CEO Andy Whelan
|
 Below is a list of the companies that made news in the healthcare sector on Tuesday, March 9, 2010.
|
 Federal health advisers on Tuesday voted in favor of an experimental drug from InterMune Inc., despite mixed evidence of whether it provides significant benefits for patients with a rare lung disease.
|
